Previous Close | 4.76 |
1-Year Change | 95.08% |
6-Months Change | 23% |
3-Months Change | -8.99% |
Moving Avg (50d) | 5.3737 |
Moving Avg (200d) | 4.3287 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 283.5M |
Beta (3-Years) | 1.28 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -38.18% |
EPS (ttm) | -0.75 |
PE Ratio (ttm) | -6.35 |
Dividend Yield | % |
Asset Description: | Aldeyra Therapeutics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-19 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
4.724 | 4.579 | 4.483 | 4.338 | 4.097 | 3.856 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.